Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Varian Medical Systems Inc (VAR)
since 2014 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Varian Medical Systems Inc.
(See page 1 of this report.) Table 2 shows the detailed insider transactions.
This company's CIK number is 203527.
Total stock buying since 2014: $0.
Total stock sales since 2014: $266,070,765.
Total stock option exercises since 2014: $157,814,248.
Table 3. Detailed insider trading at Varian Medical Systems Inc (VAR) , Part 2
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2019-02-19 | Kennedy Kolleen T (Pres. Proton Solutions, CGO) | Sale | 2,225 | 131.91 | 293,499 |
| 2019-02-15 | Toth Christopher A. (SVP and Pres. Oncology Systems) | Option Ex | 3,460 | .00 | 0 |
| 2019-02-15 | Bischoping Gary E Jr (SVP, Finance & CFO) | Sale | 300 | 131.87 | 39,561 |
| 2019-02-15 | Bischoping Gary E Jr (SVP, Finance & CFO) | Option Ex | 916 | .00 | 0 |
| 2019-02-15 | Momsen Magnus (SVP, CAO, Corporate Controller) | Option Ex | 2,204 | .00 | 0 |
| 2019-02-15 | Kennedy Kolleen T (Pres. Proton Solutions, CGO) | Option Ex | 4,269 | .00 | 0 |
| 2019-02-15 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 2,983 | .00 | 0 |
| 2019-02-15 | Wilson Dow R (President and CEO) | Option Ex | 9,024 | .00 | 0 |
| 2019-02-12 | Dugan Regina E (Director) | Option Ex | 2,384 | .00 | 0 |
| 2019-02-12 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Sale | 1,088 | 132.48 | 144,141 |
| 2019-02-12 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Option Ex | 1,088 | 67.12 | 73,026 |
| 2019-02-12 | Guertin Timothy E (Director) | Option Ex | 2,384 | .00 | 0 |
| 2019-02-12 | Eckert R Andrew (Director) | Option Ex | 2,384 | .00 | 0 |
| 2019-02-12 | Bostrom Susan L (Director) | Option Ex | 2,384 | .00 | 0 |
| 2019-02-12 | Illingworth David J (Director) | Option Ex | 2,384 | .00 | 0 |
| 2019-02-11 | Dugan Regina E (Director) | Option Ex | 1,441 | .00 | 0 |
| 2019-02-11 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Sale | 699 | 131.45 | 91,885 |
| 2019-02-11 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Option Ex | 699 | 80.40 | 56,199 |
| 2019-02-11 | Butel Jean Luc (Director) | Option Ex | 1,441 | .00 | 0 |
| 2019-02-11 | Guertin Timothy E (Director) | Option Ex | 1,441 | .00 | 0 |
| 2019-02-11 | Eckert R Andrew (Director) | Option Ex | 1,441 | .00 | 0 |
| 2019-02-11 | Bostrom Susan L (Director) | Option Ex | 1,441 | .00 | 0 |
| 2019-02-11 | Bruner Judy (Director) | Option Ex | 1,441 | .00 | 0 |
| 2019-02-11 | Illingworth David J (Director) | Option Ex | 1,441 | .00 | 0 |
| 2019-02-08 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Sale | 6,517 | 130.33 | 849,347 |
| 2019-02-08 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Option Ex | 6,517 | 112.82 | 735,247 |
| 2019-01-28 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Sale | 19,580 | 130.72 | 2,559,478 |
| 2019-01-28 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Option Ex | 19,580 | 74.15 | 1,451,915 |
| 2019-01-28 | Eckert R Andrew (Director) | Sale | 5,651 | 130.15 | 735,477 |
| 2019-01-28 | Eckert R Andrew (Director) | Option Ex | 5,651 | 57.27 | 323,632 |
| 2019-01-11 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Sale | 6,462 | 125.00 | 807,750 |
| 2019-01-03 | Momsen Magnus (SVP, CAO, Corporate Controller) | Sale | 2,800 | 110.84 | 310,363 |
| 2019-01-03 | Momsen Magnus (SVP, CAO, Corporate Controller) | Option Ex | 2,800 | 74.06 | 207,368 |
| 2018-11-15 | Kuo John W (SVP, Gen Counsel and Secretary) | Sale | 1,324 | 115.40 | 152,794 |
| 2018-11-15 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 1,324 | 75.09 | 99,416 |
| 2018-10-31 | Bischoping Gary E Jr (SVP, Finance & CFO) | Sale | 845 | 120.24 | 101,602 |
| 2018-10-29 | Momsen Magnus (SVP, CAO, Corporate Controller) | Sale | 2,700 | 111.61 | 301,349 |
| 2018-10-29 | Momsen Magnus (SVP, CAO, Corporate Controller) | Option Ex | 2,700 | 65.29 | 176,291 |
| 2018-10-29 | Kuo John W (SVP, Gen Counsel and Secretary) | Sale | 465 | 111.99 | 52,073 |
| 2018-10-29 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 465 | 80.40 | 37,386 |
| 2018-10-15 | Kuo John W (SVP, Gen Counsel and Secretary) | Sale | 862 | 105.47 | 90,918 |
| 2018-10-15 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 862 | 67.12 | 57,857 |
| 2018-10-04 | Momsen Magnus (SVP, CAO, Corporate Controller) | Sale | 100 | 110.21 | 11,021 |
| 2018-10-04 | Momsen Magnus (SVP, CAO, Corporate Controller) | Option Ex | 100 | 60.91 | 6,091 |
| 2018-09-17 | Kuo John W (SVP, Gen Counsel and Secretary) | Sale | 1,327 | 110.93 | 147,201 |
| 2018-09-17 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 1,327 | 73.76 | 97,879 |
| 2018-09-05 | Guertin Timothy E (Director) | Sale | 10,000 | 110.84 | 1,108,360 |
| 2018-09-04 | Momsen Magnus (SVP, CAO, Corporate Controller) | Sale | 2,800 | 111.68 | 312,695 |
| 2018-09-04 | Momsen Magnus (SVP, CAO, Corporate Controller) | Option Ex | 2,800 | 60.91 | 170,548 |
| 2018-08-16 | Kuo John W (SVP, Gen Counsel and Secretary) | Sale | 365 | 110.00 | 40,150 |
| 2018-08-16 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 365 | 80.40 | 29,346 |
| 2018-08-15 | Kuo John W (SVP, Gen Counsel and Secretary) | Sale | 962 | 109.51 | 105,348 |
| 2018-08-15 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 962 | 71.55 | 68,828 |
| 2018-07-16 | Kuo John W (SVP, Gen Counsel and Secretary) | Sale | 1,327 | 115.33 | 153,037 |
| 2018-07-16 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 1,327 | 73.76 | 97,879 |
| 2018-06-15 | Kuo John W (SVP, Gen Counsel and Secretary) | Sale | 1,329 | 122.55 | 162,870 |
| 2018-06-15 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 1,329 | 73.76 | 98,027 |
| 2018-05-18 | Bischoping Gary E Jr (SVP, Finance & CFO) | Option Ex | 2,819 | .00 | 0 |
| 2018-05-15 | Kuo John W (SVP, Gen Counsel and Secretary) | Sale | 1,327 | 117.16 | 155,464 |
| 2018-05-15 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 1,327 | 73.76 | 97,879 |
| 2018-05-10 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Sale | 699 | 118.20 | 82,623 |
| 2018-05-10 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Option Ex | 699 | 80.40 | 56,199 |
| 2018-04-16 | Kuo John W (SVP, Gen Counsel and Secretary) | Sale | 1,328 | 121.95 | 161,948 |
| 2018-04-16 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 1,328 | 73.76 | 97,953 |
| 2018-04-10 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Sale | 699 | 120.50 | 84,226 |
| 2018-04-10 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Option Ex | 699 | 80.40 | 56,199 |
| 2018-03-15 | Kuo John W (SVP, Gen Counsel and Secretary) | Sale | 1,328 | 125.52 | 166,695 |
| 2018-03-15 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 1,328 | 73.76 | 97,953 |
| 2018-03-12 | Momsen Magnus (SVP, CAO, Corporate Controller) | Sale | 1,556 | 126.47 | 196,791 |
| 2018-03-12 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Sale | 699 | 126.47 | 88,400 |
| 2018-03-12 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Option Ex | 699 | 80.40 | 56,199 |
| 2018-03-06 | Illingworth David J (Director) | Sale | 5,651 | 122.56 | 692,558 |
| 2018-03-06 | Illingworth David J (Director) | Option Ex | 5,651 | 57.27 | 323,632 |
| 2018-03-01 | Wilson Dow R (President and CEO) | Sale | 24,000 | 118.21 | 2,836,944 |
| 2018-03-01 | Wilson Dow R (President and CEO) | Option Ex | 24,000 | 74.06 | 1,777,440 |
| 2018-02-22 | Bostrom Susan L (Director) | Sale | 1,952 | 120.60 | 235,413 |
| 2018-02-16 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Sale | 3,513 | 121.16 | 425,621 |
| 2018-02-15 | Momsen Magnus (SVP, CAO, Corporate Controller) | Option Ex | 2,430 | .00 | 0 |
| 2018-02-15 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Option Ex | 5,264 | .00 | 0 |
| 2018-02-15 | Kuo John W (SVP, Gen Counsel and Secretary) | Sale | 6,442 | 120.72 | 777,658 |
| 2018-02-15 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 10,389 | 29.50 | 306,517 |
| 2018-02-15 | Wilson Dow R (President and CEO) | Option Ex | 16,479 | .00 | 0 |
| 2018-02-13 | Dugan Regina E (Director) | Option Ex | 1,952 | .00 | 0 |
| 2018-02-13 | Guertin Timothy E (Director) | Option Ex | 1,952 | .00 | 0 |
| 2018-02-13 | Eckert R Andrew (Director) | Option Ex | 1,952 | .00 | 0 |
| 2018-02-13 | Bostrom Susan L (Director) | Option Ex | 1,952 | .00 | 0 |
| 2018-02-13 | Illingworth David J (Director) | Option Ex | 1,952 | .00 | 0 |
| 2018-02-12 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Sale | 8,390 | 116.41 | 976,671 |
| 2018-02-12 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Option Ex | 8,390 | 80.40 | 674,556 |
| 2018-02-08 | Laret Mark R (Director) | Option Ex | 6,326 | .00 | 0 |
| 2018-02-01 | Laret Mark R (Director) | Sale | 2,161 | 126.97 | 274,382 |
| 2018-02-01 | Wilson Dow R (President and CEO) | Sale | 24,000 | 126.82 | 3,043,632 |
| 2018-02-01 | Wilson Dow R (President and CEO) | Option Ex | 24,000 | 74.06 | 1,777,440 |
| 2018-01-16 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Sale | 933 | 108.03 | 100,796 |
| 2018-01-16 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Option Ex | 933 | 81.97 | 76,478 |
| 2018-01-16 | Kuo John W (SVP, Gen Counsel and Secretary) | Sale | 863 | 108.76 | 93,856 |
| 2018-01-16 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 863 | 67.12 | 57,924 |
| 2018-01-12 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Sale | 1,089 | 107.78 | 117,369 |
| 2018-01-12 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Option Ex | 1,089 | 67.12 | 73,093 |
| 2018-01-08 | Kuo John W (SVP, Gen Counsel and Secretary) | Sale | 7,991 | 110.74 | 884,947 |
| 2018-01-08 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 7,991 | 74.38 | 594,394 |
| 2018-01-02 | Guertin Timothy E (Director) | Sale | 10,000 | 111.65 | 1,116,470 |
| 2017-12-18 | Wilson Dow R (President and CEO) | Sale | 88,766 | 111.29 | 9,879,034 |
| 2017-12-18 | Wilson Dow R (President and CEO) | Option Ex | 88,766 | 60.91 | 5,406,737 |
| 2017-12-13 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Sale | 931 | 112.97 | 105,177 |
| 2017-12-13 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Option Ex | 931 | 81.97 | 76,314 |
| 2017-12-12 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Sale | 1,087 | 110.92 | 120,571 |
| 2017-12-12 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Option Ex | 1,087 | 67.12 | 72,959 |
| 2017-11-13 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Sale | 2,021 | 107.23 | 216,709 |
| 2017-11-13 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Option Ex | 2,021 | 74.55 | 150,655 |
| 2017-10-18 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Sale | 931 | 105.00 | 97,755 |
| 2017-10-18 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Option Ex | 931 | 81.97 | 76,314 |
| 2017-10-12 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Sale | 1,088 | 101.28 | 110,194 |
| 2017-10-12 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Option Ex | 1,088 | 67.12 | 73,026 |
| 2017-10-06 | Wilson Dow R (President and CEO) | Sale | 15,059 | 102.40 | 1,541,981 |
| 2017-10-06 | Wilson Dow R (President and CEO) | Option Ex | 15,059 | 51.23 | 771,472 |
| 2017-10-06 | Eckert R Andrew (Director) | Sale | 5,651 | 102.39 | 578,594 |
| 2017-10-06 | Eckert R Andrew (Director) | Option Ex | 5,651 | 62.74 | 354,543 |
| 2017-09-13 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Sale | 933 | 107.29 | 100,099 |
| 2017-09-13 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Option Ex | 933 | .00 | 0 |
| 2017-09-12 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Sale | 1,088 | 107.33 | 116,777 |
| 2017-09-12 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Option Ex | 1,088 | .00 | 0 |
| 2017-09-07 | Wilson Dow R (President and CEO) | Sale | 15,059 | 105.47 | 1,588,348 |
| 2017-09-07 | Wilson Dow R (President and CEO) | Option Ex | 15,059 | .00 | 0 |
| 2017-08-31 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Sale | 931 | 105.00 | 97,755 |
| 2017-08-31 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Option Ex | 931 | 81.97 | 76,314 |
| 2017-08-14 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Sale | 1,088 | 97.91 | 106,524 |
| 2017-08-14 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Option Ex | 1,088 | 67.12 | 73,026 |
| 2017-08-07 | Wilson Dow R (President and CEO) | Sale | 15,059 | 96.48 | 1,452,892 |
| 2017-08-07 | Wilson Dow R (President and CEO) | Option Ex | 15,059 | 51.23 | 771,472 |
| 2017-07-13 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Sale | 933 | 105.00 | 97,965 |
| 2017-07-13 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Option Ex | 933 | 81.97 | 76,478 |
| 2017-07-13 | Kuo John W (SVP, Gen Counsel and Secretary) | Sale | 734 | 104.14 | 76,435 |
| 2017-07-13 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 734 | 81.97 | 60,165 |
| 2017-07-12 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Sale | 1,088 | 104.49 | 113,689 |
| 2017-07-12 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Option Ex | 1,088 | 67.12 | 73,026 |
| 2017-07-12 | Kuo John W (SVP, Gen Counsel and Secretary) | Sale | 863 | 104.48 | 90,166 |
| 2017-07-12 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 863 | 67.12 | 57,924 |
| 2017-07-10 | Wilson Dow R (President and CEO) | Sale | 15,060 | 103.54 | 1,559,297 |
| 2017-07-10 | Wilson Dow R (President and CEO) | Option Ex | 15,060 | 51.23 | 771,523 |
| 2017-06-20 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Sale | 26,092 | 105.00 | 2,739,660 |
| 2017-06-20 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Option Ex | 26,092 | 81.97 | 2,138,761 |
| 2017-06-13 | Kuo John W (SVP, Gen Counsel and Secretary) | Sale | 734 | 101.91 | 74,799 |
| 2017-06-13 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 734 | 81.97 | 60,165 |
| 2017-06-12 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Sale | 1,087 | 101.55 | 110,388 |
| 2017-06-12 | Kennedy Kolleen T (EVP and Pres. Oncology Sys.) | Option Ex | 1,087 | 67.12 | 72,959 |
| 2017-06-12 | Kuo John W (SVP, Gen Counsel and Secretary) | Sale | 863 | 101.57 | 87,655 |
| 2017-06-12 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 863 | 67.12 | 57,924 |
| 2017-06-09 | Guertin Timothy E (Director) | Sale | 16,000 | 102.84 | 1,645,440 |
| 2017-06-08 | Laret Mark R (Director) | Sale | 1,428 | 103.48 | 147,769 |
Insider trading activities including stock purchases, stock sales, and option exercises
of VAR listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Varian Medical Systems Inc (symbol VAR,
CIK number 203527) see
the Securities and Exchange Commission (SEC) website.